Osteoporosis and cardiovascular disease: lessons from chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Bone Metabolism

Background:

• Osteoporosis is a frequent complication of chronic kidney disease (CKD).
• CKD significantly elevates the risk of cardiovascular mortality.
• Emerging evidence links CKD's cardiovascular risks to mechanisms involving osteoporosis.

Purpose of the Study:

• To review the mechanisms by which CKD contributes to cardiovascular risk, focusing on the interplay with osteoporosis.
• To elucidate the role of hyperphosphatemia in CKD-related cardiovascular morbidity and skeletal complications.

Main Methods:

• Review of observational and mechanistic studies.
• Analysis of data linking hyperphosphatemia, vascular calcification, and skeletal remodeling in CKD patients.

Main Results:

• Hyperphosphatemia is identified as a key cardiovascular risk factor in CKD.
• Hyperphosphatemia directly stimulates vascular calcification via osteoblastic processes, contributing to cardiovascular events.
• CKD-associated hyperphosphatemia leads to disordered bone remodeling and ectopic mineralization, linking it to osteoporosis.

Conclusions:

• CKD-induced cardiovascular risk is intricately connected to osteoporosis mechanisms.
• Hyperphosphatemia in CKD is a distinct syndrome involving skeletal abnormalities and cardiovascular complications.
• Understanding these mechanisms is crucial for managing cardiovascular mortality in CKD patients.